U.S. Markets close in 3 hrs 54 mins
Stocks to Watch

Sempra outbids Buffett for Oncor, Fiat Chrysler soars, Nike gets downgraded

Curis, Inc. (CRIS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.69-0.04 (-2.31%)
As of 12:02PM EDT. Market open.
People also watch
ARQLCERSAGENARRYCYTR
Full screen
Previous Close1.73
Open1.71
Bid1.68 x 1500
Ask1.69 x 800
Day's Range1.67 - 1.72
52 Week Range1.47 - 3.72
Volume292,095
Avg. Volume543,387
Market Cap243.16M
Beta2.48
PE Ratio (TTM)-3.45
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Curis, Inc. :CRIS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube5 days ago

    Curis, Inc. :CRIS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Curis, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Curis, Inc. – Exelixis, Inc., Infinity Pharmaceuticals, Inc., Emergent BioSolutions Inc., Bristol-Myers Squibb Company, Spectrum Pharmaceuticals, Inc., Celldex Therapeutics, Inc., Pfizer Inc., Celgene Corporation and Madrigal Pharmaceuticals, Inc. (EXEL-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents10 days ago

    Edited Transcript of CRIS earnings conference call or presentation 3-Aug-17 12:30pm GMT

    Q2 2017 Curis Inc Earnings Call

  • Associated Press17 days ago

    Curis reports 2Q loss

    On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 10 cents. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...